-
Je něco špatně v tomto záznamu ?
Crohn's Disease and Intestinal Transplantation
P. Drastich, M. Oliverius,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
PubMed
28147371
DOI
10.1159/000449093
Knihovny.cz E-zdroje
- MeSH
- Crohnova nemoc komplikace chirurgie MeSH
- dospělí MeSH
- imunosupresivní léčba škodlivé účinky MeSH
- kvalita života MeSH
- lidé MeSH
- míra přežití MeSH
- mladý dospělý MeSH
- nemoci střev etiologie chirurgie MeSH
- parenterální výživa úplná MeSH
- syndrom krátkého střeva etiologie chirurgie MeSH
- tenké střevo transplantace MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladý dospělý MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Most patients with Crohn's disease (CD) require one or more operations during their lifetime. Repeated resections and surgical complications may result in short gut in a subset of patients, typically those with extensive small bowel disease or a penetrating CD phenotype. The effects of short bowel syndrome (SBS) can range in seriousness from mild to life-threatening advanced intestinal failure. Worldwide, CD is the second leading indication for intestinal transplantation (ITx) in SBS, but the overall incidence of ITx is quite low. Key Messages: Currently, total parenteral nutrition (TPN) is the preferred treatment option for patients with SBS because of its superior survival outcome. However, TPN can fail from loss of venous access due to catheter-associated thromboses, recurrent catheter-related blood stream infections, or intestinal-failure-associated liver dysfunction. Three types of transplantations are available for CD patients - small bowel alone, liver plus small bowel and multivisceral, which includes other intra-abdominal organs. An abdominal wall transplant is required in case of abdominal wall defects or lack of free intra-abdominal space. The current 5-year survival rate of 54% following ITx of the isolated small bowel appears worse than that associated with TPN. However, outcomes are substantially improving because of surgical and technical advances and progress in medical therapy. On the other hand, ITx carries the risk of both complications (e.g., rejection, infections, and post transplant lymphoproliferative disorders) and adverse events associated with immunosuppression. CD recurrence has been reported in a few patients, but this primarily histologic recurrence might not be of great clinical importance. CONCLUSIONS: ITx has become a well-established treatment for those who fail on TPN and who have life-threatening complications. Fortunately, it concerns only a small proportion of CD patients, but it does offer reasonable survival and quality of life. Primary management of patients with small bowel failure should be provided by a center experienced in medical intestinal rehabilitation, nutrition, and transplantation of other solid organs.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013277
- 003
- CZ-PrNML
- 005
- 20170428121437.0
- 007
- ta
- 008
- 170413s2017 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000449093 $2 doi
- 035 __
- $a (PubMed)28147371
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Drastich, Pavel $u Hepatogastroenterology Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 245 10
- $a Crohn's Disease and Intestinal Transplantation / $c P. Drastich, M. Oliverius,
- 520 9_
- $a BACKGROUND: Most patients with Crohn's disease (CD) require one or more operations during their lifetime. Repeated resections and surgical complications may result in short gut in a subset of patients, typically those with extensive small bowel disease or a penetrating CD phenotype. The effects of short bowel syndrome (SBS) can range in seriousness from mild to life-threatening advanced intestinal failure. Worldwide, CD is the second leading indication for intestinal transplantation (ITx) in SBS, but the overall incidence of ITx is quite low. Key Messages: Currently, total parenteral nutrition (TPN) is the preferred treatment option for patients with SBS because of its superior survival outcome. However, TPN can fail from loss of venous access due to catheter-associated thromboses, recurrent catheter-related blood stream infections, or intestinal-failure-associated liver dysfunction. Three types of transplantations are available for CD patients - small bowel alone, liver plus small bowel and multivisceral, which includes other intra-abdominal organs. An abdominal wall transplant is required in case of abdominal wall defects or lack of free intra-abdominal space. The current 5-year survival rate of 54% following ITx of the isolated small bowel appears worse than that associated with TPN. However, outcomes are substantially improving because of surgical and technical advances and progress in medical therapy. On the other hand, ITx carries the risk of both complications (e.g., rejection, infections, and post transplant lymphoproliferative disorders) and adverse events associated with immunosuppression. CD recurrence has been reported in a few patients, but this primarily histologic recurrence might not be of great clinical importance. CONCLUSIONS: ITx has become a well-established treatment for those who fail on TPN and who have life-threatening complications. Fortunately, it concerns only a small proportion of CD patients, but it does offer reasonable survival and quality of life. Primary management of patients with small bowel failure should be provided by a center experienced in medical intestinal rehabilitation, nutrition, and transplantation of other solid organs.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a Crohnova nemoc $x komplikace $x chirurgie $7 D003424
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunosupresivní léčba $x škodlivé účinky $7 D007165
- 650 _2
- $a nemoci střev $x etiologie $x chirurgie $7 D007410
- 650 _2
- $a tenké střevo $x transplantace $7 D007421
- 650 _2
- $a parenterální výživa úplná $7 D010289
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a syndrom krátkého střeva $x etiologie $x chirurgie $7 D012778
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Oliverius, Martin
- 773 0_
- $w MED00173707 $t Digestive diseases (Basel, Switzerland) $x 1421-9875 $g Roč. 35, č. 1-2 (2017), s. 127-133
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28147371 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170428121758 $b ABA008
- 999 __
- $a ok $b bmc $g 1199742 $s 974055
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 35 $c 1-2 $d 127-133 $e 20170201 $i 1421-9875 $m Digestive diseases $n Dig Dis $x MED00173707
- LZP __
- $a Pubmed-20170413